0001209191-16-133601.txt : 20160721 0001209191-16-133601.hdr.sgml : 20160721 20160721160817 ACCESSION NUMBER: 0001209191-16-133601 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160719 FILED AS OF DATE: 20160721 DATE AS OF CHANGE: 20160721 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: bluebird bio, Inc. CENTRAL INDEX KEY: 0001293971 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 150 SECOND STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 339-499-9300 MAIL ADDRESS: STREET 1: 150 SECOND STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 FORMER COMPANY: FORMER CONFORMED NAME: Genetix Pharmaceuticals Inc DATE OF NAME CHANGE: 20040616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sullivan Eric CENTRAL INDEX KEY: 0001601797 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35966 FILM NUMBER: 161777500 MAIL ADDRESS: STREET 1: GOODWIN PROCTER LLP STREET 2: 53 STATE ST CITY: BOSTON STATE: MA ZIP: 02109 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-07-19 0 0001293971 bluebird bio, Inc. BLUE 0001601797 Sullivan Eric C/O BLUEBIRD BIO, INC. 150 SECOND STREET CAMBRIDGE MA 02141 0 1 0 0 Principal Accounting Officer Common Stock 2016-07-19 4 S 0 857 45.40 D 4656 D Common Stock 2016-07-20 4 S 0 1849 44.8521 D 2807 D Common Stock 2016-07-20 4 S 0 101 45.3351 D 2706 D Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units. This sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2016. The range in prices for the transaction reported on this line was $44.30 to $45.30. The average weighted price was $44.8521. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The range in prices for the transaction reported on this line was $45.32 to $45.35. The average weighted price was $45.3351. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Jason F. Cole, Attorney-in-Fact 2016-07-21